Catheter Precision VTAK
NYSE VTAK
$0.21 0.00 (-0.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Catheter Precision (VTAK) Amortization of Deferred Charges (2025 - 2026)

Catheter Precision (VTAK) posted quarterly Amortization of Deferred Charges of $97000.0 for Q1 2026, up 321.74% year-over-year from $23000.0 in Q1 2025, and up 438.89% quarter-over-quarter from $18000.0 in Q4 2025.

Catheter Precision (VTAK) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

Catheter Precision (VTAK) has reported Amortization of Deferred Charges for 2 consecutive years, with $97000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges rose 321.74% year-over-year to $97000.0; the TTM figure through Mar 2026 stood at $119000.0 (changed N/A YoY), while the FY2025 annual figure was $45000.0, changed N/A from the prior year.
  • Amortization of Deferred Charges rose to $97000.0 in Q1 2026 per VTAK's latest filing, from $18000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $97000.0 in Q1 2026 and bottomed at -$13000.0 in Q2 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Catheter Precision 570,646.14 -1.27 Mn 98,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 97,000.00
Mar 31, 2026 97,000.00
Dec 31, 2025 18,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 17,000.00
Sep 30, 2025 17,000.00
Jun 30, 2025 -13,000.00
Jun 30, 2025 -13,000.00
Mar 31, 2025 23,000.00
Mar 31, 2025 23,000.00